Please use this identifier to cite or link to this item:
Title: Coriolis efect particles segregator (CEPS): the feasibility of scaling up lab‑on‑a‑chip separation
Authors: Tan, Yong Zen
Zamani, Farhad
Tian, Ju
Chew, Jia Wei
Keywords: Engineering::Chemical engineering
Issue Date: 2022
Source: Tan, Y. Z., Zamani, F., Tian, J. & Chew, J. W. (2022). Coriolis efect particles segregator (CEPS): the feasibility of scaling up lab‑on‑a‑chip separation. Microfluidics and Nanofluidics, 26(2), 14-.
Project: MOE/2018/MDT34
2019-T1-002- 065
Journal: Microfluidics and Nanofluidics
Abstract: Effective separation is critical in a wide range of applications. The focus here is on disease diagnosis in the healthcare industry and blood constituent separation in the medical industry, whereby lab-on-a-chip devices are generally limited by low throughput, which restricts separation on a practical scale. In this study, we conceive a novel Coriolis Effect Particles Segregator (CEPS), in which Coriolis force is harnessed as the key driving force for separation in a simple milli-fluidic straight-through channel and milliliters (rather than microliters) of fluids can be readily handled. First, Matlab simulations based on theoretical equations prove that perfect separation of 8 and 15 μm particles is possible. Then, Comsol simulations were performed to ascertain if an off-the-shelf milli-fluidic glass tube, coupled with Y-tube fittings as inlets and outlets, can be used. Finally, to provide proof-of-concept, a prototype was designed and built to demonstrate the practical feasibility of the CEPS. In contrast to theoretical calculations, separation was not as perfect, due to pressure differential at the outlets, need to further optimize the operating parameters (e.g., rotation speed, flow rates), adhesion of particles to channel wall, and vibration effects of the assembled setup. This study showcases the feasibility of scaling up the lab-on-a-chip design into a more practical-scale CEPS, providing a new platform for separations particularly of blood constituents (e.g., red blood cells, circulating tumor cells).
ISSN: 1613-4982
DOI: 10.1007/s10404-022-02521-7
Rights: © 2022 The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. All rights reserved.
Fulltext Permission: none
Fulltext Availability: No Fulltext
Appears in Collections:SCBE Journal Articles

Page view(s)

Updated on Feb 8, 2023

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.